Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors
Top Cited Papers
- 1 April 2004
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 103 (7) , 2467-2473
- https://doi.org/10.1182/blood-2003-05-1457
Abstract
Chronic joint disease from repeated bleeding into joints is a serious complication of hemophilia. To measure the extent of and to identify risk factors for deviations from normal in joint range of motion (ROM), we used cross-sectional data collected from 4343 males with hemophilia aged 2 to 19 years who received care at 136 US hemophilia treatment centers (HTCs). Factors examined included age, race/ethnicity, family history, insurance status, age at diagnosis and first HTC visit, frequency of HTC visits, hemophilia type, bleeding frequency, prophylaxis use, inhibitor status, body mass index (BMI), and recent orthopedic procedures. Trained personnel using a standard protocol obtained ROM measurements on 10 joints (hips, knees, shoulders, elbows, and ankles). Analyses used multiple linear regression to model overall ROM limitation separately by disease severity. For persons in all severity groups, joint ROM limitation was positively associated with older age, nonwhite race, and increased BMI. For those with severe disease, ROM limitation was also positively associated with number of bleeds and was greater for those with inhibitors or recent orthopedic procedures. We conclude that ROM limitations begin at an early age, especially for those with severe and moderate disease, and that BMI is an important, potentially modifiable risk factor.Keywords
This publication has 5 references indexed in Scilit:
- Home‐based factor infusion therapy and hospitalization for bleeding complications among males with haemophiliaHaemophilia, 2001
- Prevalence of the prothrombin 20210 G-to-A variant in blacks: Infants, patients with venous thrombosis, patients with myocardial infarction, and control subjectsJournal of Laboratory and Clinical Medicine, 1998
- A racial difference in the prevalence of the Arg506->Gln mutationThrombosis Research, 1996
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- "Founder" effect in different families with haemophilia B mutationThe Lancet, 1990